Aeluma, Inc.
Aeluma stock rose 7.0% in pre-market trading after announcing a partnership with Sumitomo Chemical Advanced Technologies to develop and manufacture photonics wafers for AI datacom. The company is set to report Q4 and full-year 2026 earnings on September 16. The sole analyst's price target of $30.50 suggests significant upside from current levels.
Denbaars Steven sold 25,000 shares of Aeluma, Inc. (ALMU) at an average of $13.83 ($13.82–$13.84, $0.35M total) across 2 trades over 2026-08-26 to 2026-08-27.
MarketBeat highlights NVIDIA’s broader photonics investment and says the global photonics market is about $1.25T, growing mid-single digits through the next decade, with silicon photonics rising ~30% annually. It profiles Aeluma (NASDAQ: ALMU), citing quantum-dot lasers and a manufacturing method that grows optical-quality substrate on silicon. The article notes Aeluma is pre-revenue, seeks data-center/defense partnerships for design wins and prototype certifications, and targets production and
Over the past 7 days, AlphAI's AI scored 1 news story mentioning ALMU (Aeluma, Inc.). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.
Recent ALMU coverage spans insider activity, market movers and technology.
In the last 30 days, ALMU insiders filed 2 SEC Form 4 transactions — no purchases and 2 sales ($346K). The most active reporter was Denbaars Steven with 2 filings.
Aeluma stock rose 7.0% in pre-market trading after announcing a partnership with Sumitomo Chemical Advanced Technologies to develop and manufacture photonics wafers for AI datacom. The company is set to report Q4 and full-year 2026 earnings on September 16. The sole analyst's price target of $30.50 suggests significant upside from current levels.
The insider sale may signal reduced confidence, potentially pressuring the stock short-term.
Near-term trading focus is on whether partnership/design wins emerge before additional capital is needed; adoption and dilution risks remain key.
Insider selling disclosed via Form 4; likely limited incremental fundamental signal given pre-arranged 10b5-1, but can affect near-term sentiment/positioning.
Insider selling under a pre-arranged 10b5-1 plan is typically low-signal for near-term fundamentals, but can modestly affect sentiment.
AlphAI scores every news story that mentions ALMU with an AI model for sentiment and relevance, and aggregates insider trades from Aeluma, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Aeluma stock rose 7.0% in pre-market trading after announcing a partnership with Sumitomo Chemical Advanced Technologies to develop and manufacture photonics wafers for AI datacom. The company is set to report Q4 and full-year 2026 earnings on September 16. The sole analyst's price target of $30.50 suggests significant upside from current levels.
2 min readDenbaars Steven sold 25,000 shares of Aeluma, Inc. (ALMU) at an average of $13.83 ($13.82–$13.84, $0.35M total) across 2 trades over 2026-08-26 to 2026-08-27.
1 min readMarketBeat highlights NVIDIA’s broader photonics investment and says the global photonics market is about $1.25T, growing mid-single digits through the next decade, with silicon photonics rising ~30% annually. It profiles Aeluma (NASDAQ: ALMU), citing quantum-dot lasers and a manufacturing method that grows optical-quality substrate on silicon. The article notes Aeluma is pre-revenue, seeks data-center/defense partnerships for design wins and prototype certifications, and targets production and
5 min readKlamkin Jonathan (Chief Executive Officer) sold 8,200 shares of Aeluma, Inc. (ALMU) at $26.25 ($0.22M total) on 2026-06-01 under a Rule 10b5-1 trading plan.
1 min readKlamkin Jonathan (Chief Executive Officer) sold 1,600 shares of Aeluma, Inc. (ALMU) at $25.12 on 2026-06-01 under a Rule 10b5-1 trading plan.
2 min readKlamkin Jonathan (Chief Executive Officer) sold 7,900 shares of Aeluma, Inc. (ALMU) at $24.39 ($0.19M total) on 2026-06-01 under a Rule 10b5-1 trading plan.
1 min readKlamkin Jonathan (Chief Executive Officer) sold 1,400 shares of Aeluma, Inc. (ALMU) at $23.32 on 2026-06-01 under a Rule 10b5-1 trading plan.
2 min readKlamkin Jonathan (Chief Executive Officer) sold 900 shares of Aeluma, Inc. (ALMU) at $22.19 on 2026-06-01 under a Rule 10b5-1 trading plan.
2 min readAeluma (NASDAQ: ALMU) said the U.S. Department of Commerce announced proposed CHIPS Act incentives of more than $2 billion for nine companies to accelerate quantum computing, shifting from R&D to manufacturing. Aeluma supported one company that signed a letter of intent, with involvement contingent on a subcontract. Aeluma cited its scalable wafer platform and recent U.S. contracts for quantum materials and lasers.
4 min readMarketBeat.com compares Cerebras Systems (CBRS) and Aeluma (ALMU). It reports Aeluma has a consensus price target of $25.33 (about 4% upside) and a stronger consensus rating. The article also states Cerebras has higher revenue and earnings, while profitability metrics are compared via net margin and returns on equity/assets.
7 min read
